April 21, 2021
Dr. Jim Galvin, a professor and Director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine, talks about advanced clinical trial results for treating mild Alzheimer’s Disease, what it means, and the upcoming June, 2021 final decision by the FDA.
Read the Full article
Tags: Alzheimer’s disease, James galvin